Skip to content Skip to sidebar Skip to footer

Newsletter

Blue Chip Stocks

5 of the most important investor conferences Australian investors need to know about in 2026!

In this article, we recap the 5 most important investor conferences that Australian investors should know about. The ones we mention below stand out above any others, because companies (as well as investors, brokers and IR professionals) from all over the country flock to these events on the scale few others do. Not just to hear…

ByNick SundichJanuary 16, 2026

Car Group (ASX:CAR): Successful in Australia, but now going for global growth

For most of the listed life of Car Group (ASX:CAR), it has been known after carsales.com.au; its original car classifieds site in Australia. It was founded in 1997 and now has over 200,000 new and used cars for sale, but the company has even bigger ambitions. But the company, a member of the ASX 50…

ByNick SundichJanuary 16, 2026

QBE Insurance Group (ASX:QBE): Is this the 4-decade long Sydney Swans sponsor the ASX insurer to buy?

If you're a fan of sport, you'd know that QBE Insurance Group (ASX:QBE) have been a sponsor of the Sydney Swans for over 40 years - one of the longest-running sponsorships in global sport. One not knowing anything else about the company would have to assume it must be doing something right to survive as long…

ByNick SundichJanuary 15, 2026

Suncorp (ASX:SUN): 18 months removed from retail banking, is it faring better?

In July 2024, Suncorp (ASX:SUN) ceased to be in retail banking following the sale of this division to ANZ. This came after a 2 year battle to get the deal through. Now the company is a pure-play insurer, it must be looked at with a different lens. It'd never stack up to the Big 4, but…

ByNick SundichJanuary 14, 2026

Liontown Resources (ASX:LTR): From riches to rags, now back to riches again? Here’s what 2026 holds

We've all heard the saying 'rags to riches' and when Liontown (ASX:LTR) found Kathleen Valley, it was the perfect illustration of what it means. Liontown (now known just as Liontown after dropping the 'Resources' part of its name) was just another small cap explorer, hoping to stumble across a major deposit and turning it into…

ByNick SundichJanuary 13, 2026

ASX Takeovers in 2026: Here are 5 Struggling Companies We Think Could be Next!

There could be a fair number of ASX Takeovers in 2026 - the year is not less than a fortnight old, and >$10bn steel giant BlueScope (ASX:BSL) was a target. We thought now would be a good time to consider which other companies could be targets. Before we go into it, we would point out that…

ByNick SundichJanuary 13, 2026

Cochlear (ASX:COH) is still a long term growth story you should listen to

Cochlear is one of few stocks that has created immense shareholder value and has also greatly improved the lives of its users. Yes, this can be said with respect to many ASX health stocks, but this one can hang its hat on its societal impacts more than most other companies. What are the Best ASX Stocks…

ByNick SundichJanuary 9, 2026

The Dogs of the Dow (or ASX) Strategy: Should Investors Consider It?

As investors consider their strategies for 2026, The Dogs of the Dow (or ASX) strategy could be one of them. What are the Best ASX Stocks to invest in? Check our buy/sell tips [sg_popup id="23914" event="click"][/sg_popup] What is a Dogs of the Dow strategy? It is a popular stock market investment approach that involves selecting the 10 highest-yielding…

ByNick SundichJanuary 8, 2026

Novo Nordisk (CPH: NOVO-B): It’s not all smooth sailing for the US$180bn company behind obesity drug Ozempic

Not many 100-year old healthcare stocks see a sudden 30% jump in sales in one year and become the largest capitalised company on their entire continent but Novo Nordisk (CPH: NOVO-B) is one such stock that did just that. Its a Danish drug maker that is behind weight loss drugs Ozempic and Wegovy. For much of…

ByNick SundichJanuary 8, 2026

There’s a new ACCC merger control regime! Here’s what investors need to know

With this new year comes a new ACCC merger control regime. Now that it is formally in place, investors who don't yet know about the regime should. So to those investors...you're welcome. What are the Best ASX Stocks to invest in right now? Check our buy/sell tips [sg_popup id="23914" event="click"][/sg_popup] What you need to know about the ACCC…

ByNick SundichJanuary 5, 2026

the Kick-ass Multipurpose WordPress Theme

Blue Chip Stocks

5 of the most important investor conferences Australian investors need to know about in 2026!

Car Group (ASX:CAR): Successful in Australia, but now going for global growth

QBE Insurance Group (ASX:QBE): Is this the 4-decade long Sydney Swans sponsor the ASX insurer to buy?

Suncorp (ASX:SUN): 18 months removed from retail banking, is it faring better?

Liontown Resources (ASX:LTR): From riches to rags, now back to riches again? Here’s what 2026 holds

ASX Takeovers in 2026: Here are 5 Struggling Companies We Think Could be Next!

Cochlear (ASX:COH) is still a long term growth story you should listen to

The Dogs of the Dow (or ASX) Strategy: Should Investors Consider It?

Novo Nordisk (CPH: NOVO-B): It’s not all smooth sailing for the US$180bn company behind obesity drug Ozempic

There’s a new ACCC merger control regime! Here’s what investors need to know

Stocks in Spotlight

Investing in the Year of the Rat

2020, the Golden Year

Market trouble spots to avoid in 2020

Blue Chip Stocks

Stocks in Spotlight

Add Your Heading Text Here